Sangamo
Sangamo focuses on research, development and commercialization of deoxyribonucleic acid binding proteins for therapeutic gene regulation.
Business Model:
Revenue: $112.1M
Employees: 201-500
Industries / Tags:
Detailed Sangamo Information
Geographic Data
Address: 7000 Marina Boulevard
City: Brisbane
State: CA
Zip: 94005
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$146M
Raised Total:$72M
Social
Metrics
2,295,106Website Global Rank
8,235Website Monthly Traffic
Twitter Followers
Description
Sangamo focuses on research, development and commercialization of deoxyribonucleic acid binding proteins for therapeutic gene regulation.
Contact Phone:
+15109706000
Contact Email:
Sangamo went public on 4/14/2000 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
4/14/2000
Ticker Symbol:
SGMO
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2018 | Grant | 1 | $8M |
California Institute for Regenerative Medicine California Institute for Regenerative Medicine California Institute for Regenerative Medicine California Institute for Regenerative Medicine |
4/2019 | Post-IPO Equity | $145.5M | 2/2018 | Grant | 1 | $11M |
National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health |
9/2013 | Post-IPO Equity | $74.2M | 4/2000 | IPO | $52.5M | 4/2018 | Post-IPO Equity | $200M | 6/2017 | Post-IPO Equity | $83.4M |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
